Upadacitinib T7503
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.
CAS nr:
1310726-60-3
Purity:
98%
Molecular Weight:
380,37
SMILES:
CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F
Formula:
C17H19F3N6O
Pathway:
JAK/STAT signaling,Chromatin/Epigenetic,Stem Cells,Angiogenesis
Target:
JAK,JAK,JAK,JAK
